EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,405 | +7.3% | 7,560 | +16.9% | 0.00% | – |
| Q2 2023 | $56,272 | -94.3% | 6,468 | -98.1% | 0.00% | – |
| Q1 2023 | $983,024 | -17.1% | 334,362 | -1.3% | 0.00% | – |
| Q4 2022 | $1,185,086 | +1419.3% | 338,596 | +3306.1% | 0.00% | – |
| Q3 2022 | $78,000 | +18.2% | 9,941 | +19.7% | 0.00% | – |
| Q2 2022 | $66,000 | -37.1% | 8,302 | -4.5% | 0.00% | – |
| Q1 2022 | $105,000 | -88.7% | 8,689 | -88.5% | 0.00% | – |
| Q4 2021 | $928,000 | +654.5% | 75,800 | +541.4% | 0.00% | – |
| Q3 2021 | $123,000 | +141.2% | 11,818 | +107.6% | 0.00% | – |
| Q2 2021 | $51,000 | -26.1% | 5,694 | -16.3% | 0.00% | – |
| Q1 2021 | $69,000 | – | 6,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |